In the present study we show that HF patients are also characterized by an increased activation potential of the AP, as demonstrated by increased plasma levels of FD that promotes AP activation and is significantly associated with clinical and neurohormonal disease severity. The gene discussed is ELP1; the disease is hydrops fetalis.